AzTrials
AzTrials

Neurodevelopmental DisordersNCT06852989

Shared Interactive Book Reading in Preschool Children With Neurodevelopmental Disorders: Effects on Language Development and Reading Habits

An observational study of Neurodevelopmental Disorders and Autism Spectrum Disorder, run by Fondazione Don Carlo Gnocchi ETS at 1 site in Italy.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this observational retrospective study is to explore the effects of a parent-based book reading intervention on children with neurodevelopmental disorders. The project consisted of interactive lessons for parents and shared reading experiences. Read more about this study

Who is it for?
Ages 1 year to 6 years
What is being tested?
Shared book reading intervention
How many people
53 participants
Where
1 siteItaly
Study dates
13 Feb 2025to Aug 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 6 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Preschool children with neurodevelopmental disorders attending Fondazione Don Carlo Gnocchi's rehabilitation center

Who may be able to join

  • age between 1 and 6 years old
  • having attended at least 2 out of 5 parent training meetings and 2 out of 9 reading aloud sessions
  • at least one caregiver with a good command of the Italian language,
  • having given written consent to participate

Who cannot join

  • cerebral palsy or severe sensory disorder (deafness, blindness)
  • limited command of the italian language
  • lack of informed consent

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Fondazione Don Carlo Gnocchi Onlus

    Rome

Other trials in Italy

About this study

The goal of this observational retrospective study is to explore the effects of a parent-based book reading intervention on children with neurodevelopmental disorders. The project consisted of interactive lessons for parents and shared reading experiences. It took place between May 2021 and June 2022 in Rome and at the time children were receiving neuropsychomotor and speech therapy sessions based on the developmental profile.

The investigators'primary goal is to investigate lexical quotients of children who participated in the project to explore whether it had an impact on their language development. The secondary goal is to assess shared reading habits.

Read more

For both outcome measures, researchers will compare the group who partecipated in the study with a cohort of children with the same characteristics who also attended Fondazione Don Carlo Gnocchi for rehabilitation purposes.

Patients and their family will not be asked for any further engagement because all data will be taken from medical records.

Being tested
Shared book reading intervention
Keywords
shared reading, early literacy, neurodevelopmental disorder, autism, intellectual disability, vocabulary, shared reading habits, language disorders, shared interactive book reading
Medical subject headings
Neurodevelopmental Disorders, Autism Spectrum Disorder, Intellectual Disability, Literacy, Autistic Disorder, Language Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Shared book reading interventionOther

    Also called Parent-based book reading intervention

    The study group participated in a parent training program focusing on shared interactive reading practices and attended nine read-aloud meetings with their children under the supervision of a trained librarian.

Study groups in NCT06852989
Study groupRoleWhat they receive
Study group27 children with neurodevelopmental disorders
Receives: Other: Shared book reading intervention
Comparison group26 children with neurodevelopmental disorders

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lexical quotients (receptive and expressive)

    We will analyze receptive and expressive lexical quotient of both study and comparison group.

    Measured: February 2025 - August 2025

Secondary outcomes (1)
  1. Non-standardized shared-reading habits questionnaire

    We will analyze the impact of the project on families' shared reading habits through a custom-built self-administered questionnaire. The questionnaire has been delivered at the beginning and at the end of the project.

    Measured: February 2025 - August 2025

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Feb 2025
  2. Study start13 Feb 2025
  3. Primary completionAug 2025 (estimated)
  4. Study completionAug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
53 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06852989
Sponsor's protocol ID
SIBR-PN
Status last verified
Feb 2025
First submitted
19 Feb 2025
Last updated
28 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Neurodevelopmental Disorders and Autism Spectrum Disorder, run by Fondazione Don Carlo Gnocchi ETS at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 28 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lexical quotients (receptive and expressive) (time frame: February 2025 - August 2025). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in